Tredje AP-fonden
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1650290
SE-111 91 STOCKHOLM, V7
Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$29,979,179
+$6,994,685 QoQ
Shares Held
48,079
+61.6% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#163
of 1,322 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $108,189,503 across 9 Biotechnology names. REGN ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
48,079 | $29,979,179 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,459 | $29,535,069 | |
| 3 | RPRX |
Royalty Pharma plc
|
219,990 | $12,334,839 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,206 | $11,200,122 | |
| 5 | INCY |
Incyte Corp
|
67,814 | $7,687,395 | |
| 6 | ASND |
Ascendis Pharma A/S
|
20,448 | $5,453,890 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
27,000 | $5,056,560 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
60,944 | $3,487,215 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,979,179 | 48,079 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $22,984,494 | 29,748 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,604,637 | 16,330 | Shares | Sole | 2026-02-06 | |
| 2024-12-31 | $19,232,910 | 27,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $28,383,480 | 27,000 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $28,377,810 | 27,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $25,987,230 | 27,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,073,509 | 4,638 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $39,590,136 | 48,107 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $35,085,589 | 48,829 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $40,023,545 | 48,710 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $20,092,775 | 27,849 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $18,080,082 | 26,246 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,350,908 | 9,052 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,322,097 | 9,052 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,716,519 | 9,052 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,478,089 | 9,052 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,055,904 | 9,052 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,282,863 | 9,052 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,373,111 | 9,052 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,067,128 | 9,052 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $5,645,279 | 9,052 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $7,434,703 | 15,226 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||